Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.71%
1,092.80
-7.77
-0.71%
1,100.571,098.941,103.801,084.24
SIXC
Communications
SIXC
Communications
SIXC
-0.07%
604.74
-0.41
-0.07%
605.15605.15606.69602.76
SIXE
Energy
SIXE
Energy
SIXE
+1.64%
1,214.80
+19.61
+1.64%
1,195.191,204.711,221.691,204.71
SIXI
Industrials
SIXI
Industrials
SIXI
-0.88%
1,724.57
-15.34
-0.88%
1,739.911,734.501,734.501,710.67
SIXM
Financials
SIXM
Financials
SIXM
+0.14%
639.43
+0.87
+0.14%
638.56640.21645.32638.69
SIXR
Staples
SIXR
Staples
SIXR
+0.91%
839.15
+7.58
+0.91%
831.57840.48844.16834.54
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.06%
215.62
+2.26
+1.06%
213.36213.36215.79212.77
SIXT
Technology
SIXT
Technology
SIXT
-1.69%
3,179.52
-54.66
-1.69%
3,234.183,171.863,195.363,145.46
SIXU
Utilities
SIXU
Utilities
SIXU
+0.13%
936.91
+1.26
+0.13%
935.65937.31941.44933.16
SIXV
Health care
SIXV
Health care
SIXV
+0.24%
1,452.77
+3.51
+0.24%
1,449.261,454.771,462.651,447.95
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,365.18
-17.27
-0.72%
2,382.452,371.192,380.452,362.86
603233:SHA
Dashenlin Pharmaceutical Group Co Ltd
CN¥19.35
+3.20%
(+0.60) 1D
Apr 29, 3:00:03 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 603233...
Open
CN¥18.89
High
CN¥19.44
Low
CN¥18.78
Mkt. cap
21.18B
Avg. vol.
5.12M
Volume
9.93M
Dividend
3.36%
Quarterly dividend
CN¥0.16
Ex dividend date
Nov 6, 2025
P/E ratio
17.10
52-wk high
CN¥21.78
52-wk low
CN¥15.50
EPS
CN¥1.13
Shares outstanding
400.01M
No. of employees
41K
News stories
From sources across the web
About Dashenlin Pharmaceutical Group Co Ltd
CEO-
Employees41.1K
FoundedFeb 12, 1999
Headquarters-
SectorDrug
Websitedslyy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.57B
6.55B
7.43B
6.97B
Cost of goods sold
4.28B
4.28B
4.98B
4.46B
Cost of revenue
4.28B
4.28B
4.98B
4.46B
Research and development expenses
20.59M
16.38M
-4.51M
9.63M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
1.76B
1.77B
1.95B
1.75B
Operating expense
1.79B
1.81B
2.01B
1.78B
Total operating expenses
6.07B
6.09B
6.99B
6.24B
Operating income
499.83M
458.77M
444.06M
734.26M
Other non operating income
-4.32M
-21.09M
-144.07M
-30.33M
EBT including unusual items
474.43M
398.31M
327.29M
707.02M
EBT excluding unusual items
460.77M
406.90M
397.50M
705.04M
Income tax expense
115.00M
95.80M
128.00M
163.45M
Effective tax rate
24.24%
24.05%
39.11%
23.12%
Other operating expenses
9.12M
21.41M
54.91M
22.65M
Net income
338.17M
282.83M
154.25M
511.14M
Net profit margin
5.15%
4.32%
2.07%
7.33%
Earnings per share
-
-
-
0.45
Interest and investment income
15.69M
15.03M
149.23M
1.11M
Interest expense
-50.42M
-45.81M
-51.72M
-
Net interest expenses
-34.73M
-30.78M
97.52M
1.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
572.98M
854.65M
516.41M
806.61M
Gain or loss from assets sale
-482.86K
482.86K
-14.70M
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more